Literature DB >> 11452635

Assessment of balanced biphasic defibrillation waveforms in transthoracic atrial cardioversion.

V Krasteva1, E Trendafilova, A Cansell, I Daskalov.   

Abstract

Various electrical pulses have been used for defibrillation. The monophasic damped sinusoid waveform, initiated in 60 s, was adopted in virtually all defibrillators. Biphasic pulses were introduced recently, achieving success with less energy. A biphasic exponential waveform was modelled with 4 ms duration per phase with a balanced 3:1 ratio of the first to second phase peak voltages and implemented in a defibrillator. A version obtained by chopping the pulses with a 5 kHz frequency was also used. It was hypothesized that the modelled transmembrane voltage decay time is a parameter that could be associated with successful defibrillation. The results of cardioversion for two groups of patients with the 'classic' monophasic waveform and with the biphasic pulses were compared. The mean efficient energy with the damped sinusoid was 205 +/- 85 J, versus 88 +/- 43 J with the biphasic pulses, yielding a ratio of 2.32 (1.92 to 3.2 for fibrillation and flutter, respectively). An acceptable agreement between model data and clinical results was found. The transmembrane voltage decay time ratios for monophasic versus biphasic pulses was in the approximate range of 2.5 to 3.5.

Entities:  

Mesh:

Year:  2001        PMID: 11452635     DOI: 10.1080/03091900110038384

Source DB:  PubMed          Journal:  J Med Eng Technol        ISSN: 0309-1902


  2 in total

1.  Cardioversion of Atrial Fibrillation and Flutter: Comparative Study of Pulsed vs. Low Energy Biphasic Truncated Exponential Waveforms.

Authors:  Delphine Lavignasse; Elina Trendafilova; Elena Dimitrova; Vessela Krasteva
Journal:  J Atr Fibrillation       Date:  2019-10-31

2.  Cardioversion Efficacy Using Pulsed Biphasic or Biphasic Truncated Exponential Waveforms: A Randomized Clinical Trial.

Authors:  Anders S Schmidt; Kasper G Lauridsen; Kasper Adelborg; Peter Torp; Leif F Bach; Simon M Jepsen; Nete Hornung; Charles D Deakin; Hans Rickers; Bo Løfgren
Journal:  J Am Heart Assoc       Date:  2017-03-08       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.